MS- Patho, Diagnosis, Symptoms, Types of MS Flashcards

1
Q

MS definition

A

Chronic, autoimmune disease that affects the CNS –> myelin sheath covering of nerve fibers in the brain and spinal cord –> impairs nerves’ abilities to send electrical impulses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is correlated with MSS disability?

A

Inflammation and immune activity including T and B lymphocytes, macrophages, destructive cytokines, antibodies and complement –> results in demyelination and axon damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Factors associated with MS

A

Vitamin D deficiency, smoking, measles, canine distemper, human herpes-virus-6, Epstein-Barr, chlamydia pneumonia, first-degree relative with MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MS symptoms

A

muscle weakness, visual symptoms, unsteady gait/balance issues, pain/paresthesias, emotional/cognitive disturbances, fatigue, sexual dysfunction, speech, swallowing, abnormal sensations, sensitivity to heat, bladder and bowel problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MS diagnosis

A

At least 2 documented clinical exacerbations separated by time and space as well as 2 distinct MRI lesions separated by time and space

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DIT definition

A

simultaneous presence of gadolinium-enhancing lesions and non-enhancing lesions or a new lesion on a follow-up MRI when compared to a previous MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

DIS definition

A

distinctly different anatomical lesions on imaging occurring in areas known to be affected by MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Poser Criteria: clinically definite MS

A

2 attacks and clinical evidence of 2 separate lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Poser Criteria: laboratory-supported definite MS

A

2 attacks, either clinical or paraclinical evidence of 1 lesion, and CSF immunologic abnormalities

1 attack, clinical evidence of 2 separate lesions and CSF abnormalities

Clinical evidence of 1 and paraclinical evidence of another separate lesion, CSF abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Poser Criteria: MRI findings

A

≥4 white matter lesions, each >3mm

≥3 white matter lesions, 1 periventricular lesion ≥6mm

Ovoid lesions oriented perpendicular to ventricles

Corpus callosum lesions

Brainstem lesions

Open ring appearance of gadolinium enhancement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Poser Criteria: CSF studies

A

Normal RBCs and glucose

Normal or mildly elevated protein (5-20 mononuclear cells/ul)

Intrathecal IgG synthesis, IgG index or 24 hour synthesis rate

Increased free kappa light chains

Oligoclonal bands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CIS definition

A

first episode of neurologic symptoms that lasts at least 24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CIS is caused by what?

A

Inflammation and demyelination in one or more sites in the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Caveat of CIS

A

Just because someone has CIS doesn’t mean they’ll have MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

RRMS definition

A

Patients experience worsening of pre-existing symptoms or onset of new symptoms for periods of ≥48 hours without concomitant fever –> relapses, flare-ups, exacerbations

Contrasted by symptom-free periods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SPMS definition

A

A progression of MS where the disease course is steadily progressing, can present with or without clear-cut relapses

17
Q

PPMS definition

A

Disease course is characterized by steady decline without clear-cut relapses

18
Q

Are medications effective at treating PPMS?

A

No (but ocrelizumab/Ocrevus is indicated for this!)

19
Q

PRMS definition

A

Steady disease progression in addition to clear-cut periods of exacerbations of MS

20
Q

PRMS treatment

A

Mitoxantrone is indicated for PRMS and patients can be treated for relapses with steroids, but the disease will progress regardless of therapy